company

Cell Impact has been awarded gold medal by EcoVadis

KARLSKOGA, Sweden, Nov. 11, 2025 /PRNewswire/ -- Last year, Cell Impact was awarded silver by EcoVadis. This year, the company has…

4 months ago

LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Announces Elite Level Sponsorship of the 2025 American Nuclear Society Winter Conference & Expo

Oak Ridge, Tennessee, Nov. 11, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of…

4 months ago

OSS to Demonstrate Best-In-Class High Performance Compute Portfolio at SC25

Company to showcase portfolio of ultra-dense, high-performance computing performance solutions for commercial applications at Booth 2111 November 11, 2025 08:00…

4 months ago

Phoenix Aviation Capital and AIP Capital Announce Issuance of a $592 Million Term Loan Facility

DUBLIN and STAMFORD, Conn. and NEW YORK, Nov. 10, 2025 /PRNewswire/ -- Phoenix Aviation Capital ("Phoenix" or "the Company"), a…

4 months ago

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

November 10, 2025 21:56 ET  | Source: Vor Biopharma BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq:…

4 months ago

UST wins Indian CSR Awards 2025 for Water Conservation and Social Inclusion

Recognized for 'Most Impactful Save Water Initiative of the Year' and 'Education, Health & Livelihood Initiatives for People with Disabilities…

4 months ago

Evidium Announces $22M Funding Close to Scale Computational Medical Knowledge

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Evidium, a healthcare AI company, is building AI based on computational knowledge…

4 months ago

RUNSTACK Unveils Hypergraph Long-Term Memory for Agentic Systems

NORTH YORK, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- RUNSTACK Inc., a Canadian AI agent software company, today announced a…

4 months ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative…

4 months ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025

Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…

4 months ago